-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Abbott Laboratories with Overweight Rating, Announces Price Target of $120

Benzinga·10/07/2026 12:06:02
Listen to the news
Barclays analyst Matt Miksic initiates coverage on Abbott Laboratories (NYSE:ABT) with a Overweight rating and announces Price Target of $120.